Analysts expect that Colfax Corp (NYSE:CFX) will post $817.34 million in sales for the current fiscal quarter, Zacks reports. Seven analysts have provided estimates for Colfax’s earnings, with the highest sales estimate coming in at $852.60 million and the lowest estimate coming in at $771.40 million. Colfax reported sales of $844.93 million during the same quarter last year, which would suggest a negative year over year growth rate of 3.3%. The business is scheduled to issue its next earnings results on Friday, May 4th.

According to Zacks, analysts expect that Colfax will report full year sales of $817.34 million for the current year, with estimates ranging from $3.52 billion to $3.67 billion. For the next year, analysts anticipate that the business will report sales of $3.76 billion per share, with estimates ranging from $3.70 billion to $3.80 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side analysts that that provide coverage for Colfax.

Colfax (NYSE:CFX) last issued its earnings results on Tuesday, February 6th. The industrial products company reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.44 by $0.01. The firm had revenue of $874.00 million during the quarter, compared to the consensus estimate of $894.02 million. Colfax had a net margin of 4.28% and a return on equity of 6.11%. The company’s revenue was up 7.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.46 earnings per share.

A number of brokerages recently commented on CFX. Seaport Global Securities reiterated a “buy” rating on shares of Colfax in a research note on Wednesday, February 7th. KeyCorp lowered their target price on shares of Colfax from $46.00 to $44.00 and set an “overweight” rating for the company in a research note on Wednesday, February 7th. Robert W. Baird lowered their target price on shares of Colfax from $47.00 to $42.00 and set an “outperform” rating for the company in a research note on Wednesday, February 7th. Gabelli upgraded shares of Colfax from a “hold” rating to a “buy” rating in a research note on Wednesday, February 7th. They noted that the move was a valuation call. Finally, Stifel Nicolaus lowered their target price on shares of Colfax from $48.00 to $40.00 and set a “buy” rating for the company in a research note on Wednesday, February 7th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $44.40.

In related news, SVP A. Lynne Puckett sold 7,270 shares of the business’s stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $42.01, for a total value of $305,412.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Daniel A. Pryor sold 53,333 shares of the business’s stock in a transaction on Tuesday, December 19th. The shares were sold at an average price of $38.15, for a total transaction of $2,034,653.95. Following the completion of the sale, the executive vice president now directly owns 93,557 shares of the company’s stock, valued at $3,569,199.55. The disclosure for this sale can be found here. 10.60% of the stock is owned by insiders.

Large investors have recently made changes to their positions in the company. Toronto Dominion Bank purchased a new stake in shares of Colfax in the second quarter valued at about $118,000. The Manufacturers Life Insurance Company raised its holdings in shares of Colfax by 7.3% in the second quarter. The Manufacturers Life Insurance Company now owns 3,688 shares of the industrial products company’s stock valued at $145,000 after buying an additional 251 shares during the last quarter. FNY Managed Accounts LLC purchased a new stake in shares of Colfax in the third quarter valued at about $160,000. Valeo Financial Advisors LLC purchased a new stake in shares of Colfax in the third quarter valued at about $177,000. Finally, Itau Unibanco Holding S.A. raised its holdings in shares of Colfax by 225.8% in the fourth quarter. Itau Unibanco Holding S.A. now owns 5,170 shares of the industrial products company’s stock valued at $205,000 after buying an additional 3,583 shares during the last quarter. 75.82% of the stock is owned by institutional investors and hedge funds.

Colfax (NYSE CFX) opened at $33.22 on Thursday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.47 and a current ratio of 1.80. The company has a market cap of $4,062.18, a price-to-earnings ratio of 19.98, a P/E/G ratio of 1.16 and a beta of 1.17. Colfax has a 12 month low of $31.50 and a 12 month high of $43.29.

TRADEMARK VIOLATION NOTICE: “Zacks: Brokerages Anticipate Colfax Corp (CFX) Will Post Quarterly Sales of $817.34 Million” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another site, it was copied illegally and republished in violation of international trademark & copyright laws. The legal version of this news story can be read at https://www.thecerbatgem.com/2018/02/15/zacks-brokerages-anticipate-colfax-corp-cfx-will-post-quarterly-sales-of-817-34-million.html.

About Colfax

Colfax Corporation is an industrial manufacturing and engineering company. The Company provides air and gas handling, and fabrication technology products and services. The Company’s segments include Air and Gas handling, and Fabrication Technology. The Air and Gas Handling segment supplies a range of gas handling products, including heavy-duty centrifugal and axial fans, rotary heat exchangers, gas compressors, pumps and certain related products, as well as aftermarket services.

Get a free copy of the Zacks research report on Colfax (CFX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Colfax (NYSE:CFX)

Receive News & Ratings for Colfax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colfax and related companies with MarketBeat.com's FREE daily email newsletter.